Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma

被引:44
|
作者
Akagi, I. [2 ]
Miyashita, M. [2 ]
Ishibashi, O. [1 ]
Mishima, T. [1 ]
Kikuchi, K. [1 ]
Makino, H. [2 ]
Nomura, T. [2 ]
Hagiwara, N. [2 ]
Uchida, E. [2 ]
Takizawa, T. [1 ]
机构
[1] Nippon Med Sch, Grad Sch Med, Div Mol Med & Anat, Tokyo 1138602, Japan
[2] Nippon Med Sch, Grad Sch Med, Div Surg Organ Funct & Biol Regulat, Tokyo 1138602, Japan
关键词
cancer; esophagus; microRNA; COMPARATIVE GENOMIC HYBRIDIZATION; TUMOR-SUPPRESSOR GENE; MICRORNA-21; TARGETS; NUCLEAR EXPORT; MIR-21; PROFILES; INVASION; SURVIVAL; GAIN; PROLIFERATION;
D O I
10.1111/j.1442-2050.2011.01177.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In spite of the undisputed importance of altered expression patterns of microRNAs (miRNAs) in various cancers, there is little information on the clinicopathologic significance of cancer-related miRNAs (MIR21, MIR143, MIR144, MIR145, and MIR205) in esophageal squamous cell carcinoma (ESCC). We examined the expression levels of the precursor and mature miRNA genes in ESCC using real-time polymerase chain reaction (PCR). We also investigated the mRNA expression levels of processing elements (RNASEN, DGCR8, and DICER1) that participate in miRNA-biogenesis pathway. Furthermore, we analyzed the relationships between the expression levels of these five miRNAs and the clinicopathologic parameters of ESCC patients. The expression levels of mature MIR21 and mature MIR145 were higher in ESCC than those in normal epithelium (P < 0.05). The mature/pre ratio of MIR21 in ESCC was higher than that in normal epithelium (P < 0.05). With regard to miRNA-processing elements, the expression level of RNASEN was higher in ESCC than in normal epithelium (P < 0.05). Furthermore, altered expression of these miRNAs was related to the clinicopathologic features of ESCC patients. The high expression of mature MIR21 and mature MIR205 was associated with lymph node positivity in ESCC patients (P < 0.05). The high levels of expression of mature MIR143 and mature MIR145 were associated with recurrence of metastasis in ESCC patients (P < 0.05). The findings may imply that miRNA biogenesis is aberrantly accelerated in ESCC. Analysis of the expression levels of miRNAs should provide useful information for evaluation of the staging, prognosis, and treatment of ESCC patients.
引用
收藏
页码:523 / 530
页数:8
相关论文
共 50 条
  • [41] LncRNA MIR205HG Drives Esophageal Squamous Cell Carcinoma Progression by Regulating miR-214/SOX4 Axis
    Li, Hongle
    Jia, Jinlin
    Yang, Lijun
    Chu, Jie
    Sheng, Jinxiu
    Wang, Chang
    Meng, Weiwei
    Jia, Zimo
    Yin, Huiqing
    Wan, Junhu
    He, Fucheng
    ONCOTARGETS AND THERAPY, 2020, 13 : 13097 - 13109
  • [42] Expression correlations of NFkB signaling and miR146 a/b miR21 and let-7 expression in primary human head and neck squamous cell carcinomas
    Pajkos, G.
    Sejben, I.
    Gombos, K.
    Ember, I.
    EJC SUPPLEMENTS, 2010, 8 (05): : 206 - 206
  • [43] Association between the rs3733846 in the flanking region of miR-143/145 and risk of cervical squamous cell carcinoma
    Gong, Jianyu
    Jiang, Jike
    Qu, Jianwen
    Li, Ju
    Chen, Xin
    Ruan, Zhiguo
    Lu, Gangxu
    He, Yuxiao
    He, Xiaoshan
    Sun, Ruifen
    BIOMARKERS IN MEDICINE, 2021, 15 (11) : 891 - 897
  • [44] The restoration of the depleted miR-143 in plasma is a novel anticancer treatment for esophageal squamous cell carcinoma
    Kiuchi, Jun
    Komatsu, Shuhei
    Imamura, Taisuke
    Nishibeppu, Keiji
    Ohashi, Takuma
    Kishimoto, Takuma
    Takashima, Yusuke
    Kamiya, Hajime
    Arita, Tomohiro
    Shimizu, Hiroki
    Yamamoto, Yusuke
    Konishi, Hirotaka
    Shiozaki, Atsushi
    Fujiwara, Hitoshi
    Otsuji, Eigo
    CANCER SCIENCE, 2022, 113 : 1043 - 1043
  • [45] EXPRESSION CORRELATIONS OF NFKB SIGNALING AND MIR146 A/B MIR21 AND LET-7 EXPRESSION IN PRIMARY HUMAN HEAD AND NECK SQUAMOUS CELL CARCINOMAS
    Pajkos, G.
    Sejben, I.
    Gombos, K.
    Kiss, I.
    Baan, Sz
    Horvath, R.
    Olasz, L.
    ANTICANCER RESEARCH, 2014, 34 (10) : 6094 - 6095
  • [46] RNA sequencing-based microRNA expression signature in esophageal squamous cell carcinoma: oncogenic targets by antitumor miR-143-5p and miR-143-3p regulation
    Masumi Wada
    Yusuke Goto
    Takako Tanaka
    Reona Okada
    Shogo Moriya
    Tetsuya Idichi
    Masahiro Noda
    Ken Sasaki
    Yoshiaki Kita
    Hiroshi Kurahara
    Kosei Maemura
    Shoji Natsugoe
    Naohiko Seki
    Journal of Human Genetics, 2020, 65 : 1019 - 1034
  • [47] Dysregulation of miR-21-5p, miR-93-5p, miR-200c-3p and miR-205-5p in Oral Squamous Cell Carcinoma: A Potential Biomarkers Panel?
    Aghiorghiesei, Ovidiu
    Zanoaga, Oana
    Raduly, Lajos
    Aghiorghiesei, Alexandra Iulia
    Chiroi, Paul
    Trif, Andrada
    Buiga, Rares
    Budisan, Liviuta
    Lucaciu, Ondine
    Pop, Laura Ancuta
    Braicu, Cornelia
    Campian, Radu
    Berindan-Neagoe, Ioana
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2022, 44 (04) : 1754 - 1767
  • [48] Evaluation of the Expression Levels of miR-21-5p and miR-429 Genes in Biopsy Samples from Patients with Oral Squamous Cell Carcinoma
    Garajei, Ata
    Allameh, Abdolamir
    Azadi, Mehdi
    Emami, Azadeh
    Atashbasteh, Mostafa
    Mostafavi, Melina
    Ghaderi, Bayazid
    Inchingolo, Francesco
    Sadeghi, Masoud
    Tadakamadla, Santosh Kumar
    Mohammadi, Hady
    Tadakamadla, Jyothi
    DIAGNOSTICS, 2023, 13 (07)
  • [49] Expression of miR-205 in renal cell carcinoma and its association with clinicopathological features and prognosis
    Xu, X. -W.
    Li, S.
    Yin, F.
    Qin, L. -L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (03) : 662 - 670
  • [50] HOTAIR regulates HK2 expression by binding endogenous miR-125 and miR-143 in oesophageal squamous cell carcinoma progression
    Ma, Jian
    Fan, Yanxin
    Feng, Tingting
    Chen, Fangjun
    Xu, Zhipeng
    Li, Suqing
    Lin, Qingfeng
    He, Xiaoting
    Shi, Weihong
    Liu, Yang
    Cao, Xiufeng
    Zhu, Bin
    Liu, Zhihua
    ONCOTARGET, 2017, 8 (49) : 86410 - 86422